APA ציטוט

Aróstegui, J., Anton, J., Calvo, I., Robles, A., Speziale, A., Joubert, Y., . . . Yagüe, J. (2015). Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): Results from an open-label study. Pediatr Rheumatol Online J.

Citação norma Chicago

Aróstegui, JI, J. Anton, I. Calvo, A. Robles, A. Speziale, Y. Joubert, G. Junge, and J. Yagüe. "Long-term Efficacy and Safety of Canakinumab in Active Hyper-IgD Syndrome (HIDS): Results From an Open-label Study." Pediatr Rheumatol Online J 2015.

ציטוט MLA

Aróstegui, JI, et al. "Long-term Efficacy and Safety of Canakinumab in Active Hyper-IgD Syndrome (HIDS): Results From an Open-label Study." Pediatr Rheumatol Online J 2015.